The 15 analysts offering 12-month price forecasts for Encompass Health Corp have a median target of 84.00, with a high estimate of 94.00 and a low estimate of 68.00. The median estimate represents a +6.54% increase from the last price of 78.84.
The current consensus among 16 polled investment analysts is to Buy stock in Encompass Health Corp. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.84
Reporting Date Feb 07
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.